Transparency Market Research (TMR) has published a new report on the continuous renal replacement therapy market for the forecast period of 2019–2027. According to the report, the global continuous renal replacement therapy market was valued at ~US$ 865 Mn in 2018, and is projected to expand at a CAGR of ~7% during the forecast period.
Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10298
Global Continuous Renal Replacement Therapy Market: Overview
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=10298
Rise in Incidence of Diabetes and Hypertension to Drive Market
Increasing incidence of chronic diseases, such as diabetes and hypertension, fuels the risk of developing acute kidney injury. According to the National Diabetes Statistics report by CDC (Centers for Disease Control and Prevention), in 2017, 30.3 million people in the U.S. were suffering from diabetes, which accounted for around 9.4% of the total population. Approximately 23.1 million people were diagnosed with diabetes in the U.S. Lack of awareness about diabetes could lead to serious renal issues in the future. According to data published by WHO in May 2019, 1.13 billion people are estimated to be suffering from hypertension, globally. Rise in elevated blood pressure rates is likely to affect the patient population in low- and middle-income countries. Hypertension causes around 9.4 million deaths globally every year. It can affect AKI patients and may result in acute renal failure. This factor is propelling the demand for CRRT systems.
Request Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10298
Benefits of Continuous Renal Replacement Therapy Systems in Pediatric Patients
Technological advancements of continuous renal replacement therapy in critically-ill AKI pediatric patients have resulted in a decline in mortality rates from 4.6% to 2.4% in 2018. PrismaFlex HF20 and Aquadex are a few approved CRRT systems for pediatric patients. According to a study published by NCBI (National Center for
Request for covid19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=10298
Technological Developments to Drive CRRT Market
Technological advancements are driving innovations in continuous renal replacement therapy. Continuous renal replacement therapy devices have enabled the support of multiple organ therapy using different continuous renal replacement therapy modalities in the past few years. Technological advancements have also enabled the usage of the precision continuous renal replacement therapy principle to develop devices with upgraded circuits to extend support to other organs, apart from the kidneys. Another development is obtaining information about the patient’s health through technology-assisted devices to study and analyze multiple treatments. The development of fourth-generation continuous renal replacement therapy devices, such as ACUsmart, offers a smart and optimal device for critically-ill patients.
Global CRRT Market
Product Launch and Merger & Acquisition Strategies to Drive Global CRRT Market
The global continuous renal replacement therapy market is highly competitive in terms of number of players. Key players operating in the global continuous renal replacement therapy market include Baxter International, Inc, Nipro Corporation , Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, B. Braun Melsungen AG, Medica SPA, INFOMED SA, Medtronic (Bellco Società unipersonale a r.l.), and Toray Medical Company Limited (Toray Industries, Inc.). These players have adopted various strategies, such as product portfolio expansion, innovative products development, and investments in mergers & acquisitions to establish a strong distribution network. For instance, in February 2019, Fresenius Medical Care acquired NXStage Medical, Inc., a home dialysis product manufacturer, aiming to boost the trend of using continuous renal replacement therapy systems at home. Prominent market player Baxter International launched PrisMax in the U.S., in July 2019, to offer its product to enhance the health condition of critically-ill patients.
Trending Reports:
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/
Over the last few years, there have been noteworthy technological developments in the delivery of renal replacement therapy, principally as it refers to the critically ill patient population.
Renal replacement always utilizes a semi-permeable membrane to accomplish blood purification.
Continuous renal replacement therapy (CRRT) is a widespread optimal for the cure of ICU patients with AKI, particularly for hemodynamically unbalanced circumstances.
CRRT is carried out for about 24 hours in an ICU, making it relatively different from traditional renal replacement therapies that consist of intermittent haemodialysis durable from four to six hours or even at a reduced rate.
Therefore, CRRT was established in an effort to offer artificial kidney support to those patients who could not abide the traditional haemodialysis as traditional intermittent haemodialysis often causes hemodynamic instability in the critically ill patients.
The patients in receipt of CRRT can obtain as much as protein as well as fluid required achieving optimum nutrition.
According to the report, the global continuous renal replacement therapy market was valued at ~US$ 865 Mn in 2018, and is projected to expand at a CAGR of ~7% during the forecast period.Global Continuous Renal Replacement Therapy Market: OverviewContinuous renal replacement therapy (CRRT) is a preferred modality for managing hemodynamically patients suffering from acute kidney injury.
Moreover, surge in the number of dialysis centers across the world is expected to propel the global continuous renal replacement therapy market.Europe dominated the global continuous renal replacement therapy market in 2018, and the trend is anticipated to continue during the forecast period.
However, shortage of trained staff and high cost of CRRT systems are likely to hamper the continuous renal replacement therapy market in the region during the forecast period.Asia Pacific is expected to be a highly lucrative continuous renal replacement therapy market during the forecast period, owing to increasing healthcare infrastructure, along with rise in the incidence of acute kidney injury in the region.Request COVID Analysis on Continuous Renal Replacement Therapy Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=10298 Rise in Incidence of Diabetes and Hypertension to Drive MarketIncreasing incidence of chronic diseases, such as diabetes and hypertension, fuels the risk of developing acute kidney injury.
Hypertension causes around 9.4 million deaths globally every year.
The development of fourth-generation continuous renal replacement therapy devices, such as ACUsmart, offers a smart and optimal device for critically-ill patients.Continuous Venovenous Haemofiltration (CVVH) Mode to Lead CRRT Market Continuous venovenous hemofiltration (CVVHF) is the most preferred technique.
CVVH is more effective than continuous venovenous haemodiafiltration (CVVHDF), and may be associated with fewer complications.
Continuous Renal Replacement Therapy Market" Continuous Renal Replacement Therapy Market by Product (Systems, Disposables (Hemofilters & Bloodlines), & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) - Forecast to 2022" ", published by MarketsandMarkets™, The global CRRT market is estimated to reach USD 1.53 billion by 2022; growing at a CAGR of 7.0% during the forecast period.Don’t miss out on business opportunities in Continuous Renal Replacement Therapy MarketIncreasing prevalence of AKI and renal disorders, growing number of ICU patients, rapid growth in the aging population, and clinical advantages of CRRT over intermittent blood purification techniques are some key factors propelling the growth of this market.Continuous Renal Replacement Therapy Market : Target AudienceCRRT manufacturers, suppliers, and distributorsCRRT service providersRenal research laboratoriesRenal associations and organizationsHospitals and critical care unitsAcademic medical centers and universitiesBusiness research and consulting service providersBrowse and in-depth TOC on "NGS Sample Preparation Market" 121 - Tables40 - Figures203 - PagesTo know about the assumptions considered for the study, download the pdf brochureGrowing demand of hemofilters to drive the global CRRT market to reach USD 1.53 billion by 2022Hemofilters or artificial kidneys are one of the major components in a CRRT system.
These filters usually contain a semipermeable membrane in a hollow-fiber design.
This design enables blood to flow inside the hollow fibers and, at the same time, allows the dialysate to flow outside the fibers.
The membrane type and surface area help to determine solute and fluid removal during a CRRT procedure.Continuous Renal Replacement Therapy Market : Key QuestionsWhat are the key growth strategies adopted by major continuous renal replacement therapy market players to maintain their market position across key geographies?What is the existing developmental pipeline of major modalities among key CRRT manufacturers?Growing number of Acute Kidney Injury (AKI) patients is a key trend in CRRT market.
What impact AKI incidences will have on CRRT market during the forecast period?What alternative technologies/therapies are currently being used for AKI worldwide?
What competition they pose for key CRRT market players.
